...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Apabetalone publication in "Current Opinion in Nephrology & Hypertension"

Exactly.

Hint hint, wink wink, Kam KZ wrote the article and he knows clearly whats coming for the CKD sub-study in BETonMACE. My guess is this article is a hors d'oeuvre or anĀ appetizer for the full data. Why would he spend time writing/retweeting stuff that is a complete bust?

My guess or my wish or my confirmation bias. Take your pick.

Share
New Message
Please login to post a reply